Kovacic H N, Gallice P M, Nicoara A E, Mordoff R I, Favre R G, Crevat A D
Laboratoire de Biophysique, Faculté de Pharmacie, Marseille, France.
Oncol Res. 1998;10(6):333-9.
We previously showed that in erythrocytes from cancer patients, the sodium pump is decreased and the optimal intracellular pH for Na+/H+ antiport activity is shifted toward an acidic value. We now have studied these sodium transporters in erythrocytes from patients in remission. Moreover, we intended to explain why the transporters were impaired in erythrocytes, which have no apparent bearing on cancer tissues. The sodium pump was studied through a microcalorimetric method, and the Na+/H+ antiport by a titrimetric method. In patients in remission the sodium pump activity returned to normal: 15.10 +/- 6.00 vs. 14.12 +/- 5.28 mW/l cells for remission and control, respectively. The optimal intracellular pH for Na+/H+ antiport activity was identical in remission and control: 6.09 +/- 0.23 vs. 6.10 +/- 0.10. Restoration of sodium pump activity and optimal intracellular pH for Na+/H+ antiport activity in erythrocytes were thus linked to remission. Moreover, we showed that the impairments of the sodium transporters were due to the presence of plasma-borne factors, the existence of which explained why the sodium transporters were impaired in erythrocytes.
我们之前发现,癌症患者红细胞中的钠泵活性降低,且Na⁺/H⁺逆向转运活性的最佳细胞内pH值向酸性偏移。我们现在研究了缓解期患者红细胞中的这些钠转运蛋白。此外,我们试图解释为什么这些转运蛋白在与癌组织无明显关联的红细胞中会受损。通过微量量热法研究钠泵,通过滴定法研究Na⁺/H⁺逆向转运。在缓解期患者中,钠泵活性恢复正常:缓解期和对照组的钠泵活性分别为15.10±6.00和14.12±5.28 mW/l细胞。缓解期和对照组中Na⁺/H⁺逆向转运活性的最佳细胞内pH值相同:分别为6.09±0.23和6.10±0.10。因此,红细胞中钠泵活性的恢复以及Na⁺/H⁺逆向转运活性的最佳细胞内pH值与缓解有关。此外,我们表明钠转运蛋白的损伤是由于血浆源性因子的存在,其存在解释了为什么红细胞中的钠转运蛋白会受损。